Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties

Bioorg Med Chem Lett. 2001 Feb 12;11(3):379-82. doi: 10.1016/s0960-894x(00)00669-7.

Abstract

Pyridineethanolamine derivatives containing cyanoguanidine or nitroethylenediamine moieties were examined as human beta3 adrenergic receptor (AR) agonists. Notably, indoline derivatives 6a and 11 were potent beta3 AR agonists (beta3 EC50 = 13 and 19 nM, respectively), which showed good selectivity over binding to and minimal activation of the beta1 and beta2 ARs.

Publication types

  • Comparative Study

MeSH terms

  • Adenylyl Cyclases / drug effects
  • Adenylyl Cyclases / metabolism
  • Adrenergic beta-3 Receptor Agonists*
  • Adrenergic beta-Agonists / chemical synthesis*
  • Adrenergic beta-Agonists / chemistry
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • CHO Cells
  • Cell Membrane / chemistry
  • Combinatorial Chemistry Techniques
  • Cricetinae
  • Diamines / chemistry
  • Ethane / analogs & derivatives
  • Ethane / chemistry
  • Guanidines / chemistry
  • Humans
  • Inhibitory Concentration 50
  • Nitroparaffins / chemistry
  • Radioligand Assay
  • Receptors, Adrenergic, beta / metabolism
  • Receptors, Adrenergic, beta-3 / metabolism
  • Structure-Activity Relationship

Substances

  • Adrenergic beta-3 Receptor Agonists
  • Adrenergic beta-Agonists
  • Diamines
  • Guanidines
  • Nitroparaffins
  • Receptors, Adrenergic, beta
  • Receptors, Adrenergic, beta-3
  • nitroethane
  • Adenylyl Cyclases
  • Ethane
  • dicyandiamido